Dr. Herbert C. Ruckle, MD

Dr. Ruckle practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Ruckle's NPI, 1548360415, was assigned on September 22, 2006. Dr. Ruckle graduated from Loma Linda University School Of Medicine in 1986. Dr. Ruckle holds California license G61617.

Dr. Ruckle's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Ruckle's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Ruckle is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Ruckle to 2 more hospitals, 3 group practices and clinics, 2 medical groups, 1 physician office and 1 hospital outpatient department, each named with a free account. Dr. Ruckle's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ruckle practices, 9 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ruckle's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ruckle is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ruckle's licenses on file in 2 states: California and Minnesota.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer and prostate surgery among the conditions Dr. Ruckle treats.

CMS data shows 723 Medicare services from Dr. Ruckle across 12 procedure codes in 2024, for 304 Medicare patients. Medicare paid $56,038 for them.

CMS counts 304 Medicare patients who saw Dr. Ruckle in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ruckle's median patient age at 74, with 19% women.

In 2024, Dr. Ruckle wrote 477 Medicare Part D claims for 128 patients. 94% of them were for generic drugs. CMS names the drug for 311 of them, across 7 drugs with 11 or more claims each, at $15,609 in total drug cost. In 2023, CMS named 294 claims across 6 drugs.

Dr. Ruckle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ruckle as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 59 papers to Dr. Ruckle, published from 2006 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Nephrectomy. Dr. Ruckle has published most often in Urology. Dr. Ruckle's most frequent co-authors are Paul D. Lui, MD, Muhannad Mahmoud Alsyouf, MD and Dalton Duane Baldwin, MD.

Dmand AI links Dr. Ruckle to 2 clinical trials. Conditions studied include Prostatic Diseases, Prostatic Hyperplasia and Prostatic Neoplasms.

CMS Open Payments shows 47 general payments to Dr. Ruckle from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. Intuitive Surgical, Inc. paid the most, $2,118.

Dmand AI lists 10 awards for Dr. Ruckle, most recently ACS Fellow in 2013.

Dr. Ruckle graduated from Loma Linda University School Of Medicine in 1986. Dr. Ruckle is a member of AOA, American Association of Clinical Urologists, ACS, AUA, CMA and CA Urological Association.

Dr. Ruckle is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.